BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11374361)

  • 1. Probenecid-associated alterations in valproic acid pharmacokinetics in rats: can in vivo disposition of valproate glucuronide be predicted from in vitro formation data?
    Yeleswaram S
    Drug Metab Dispos; 2001 May; 29(5):777-8. PubMed ID: 11374361
    [No Abstract]   [Full Text] [Related]  

  • 2. Probenecid-associated alterations in valproic acid pharmacokinetics in rats: can in vivo disposition of valproate glucuronide be predicted from in vitro formation data?
    Ward ES; Pollack GM; Brouwer KL
    Drug Metab Dispos; 2000 Dec; 28(12):1433-9. PubMed ID: 11095580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probenecid-associated alterations in valproate glucuronide hepatobiliary disposition: mechanistic assessment using mathematical modeling.
    Ward ES; Pollack GM; Brouwer KL
    J Pharmacol Exp Ther; 2001 Apr; 297(1):141-7. PubMed ID: 11259538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproic acid uptake by bovine brain microvessel endothelial cells: role of active efflux transport.
    Gibbs JP; Adeyeye MC; Yang Z; Shen DD
    Epilepsy Res; 2004 Jan; 58(1):53-66. PubMed ID: 15066675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uricosuric potency of 2-substituted analogs of probenecid.
    Blanchard KC; Maroske D; May DG; Weiner IM
    J Pharmacol Exp Ther; 1972 Feb; 180(2):397-410. PubMed ID: 4622053
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics, drug interactions, and tolerability of valproate.
    DeVane CL
    Psychopharmacol Bull; 2003; 37 Suppl 2():25-42. PubMed ID: 14624231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ureogenesis by two hypouricemic drugs (probenecid and benzbromarone). Comparison with allopurinol.
    Sanchez-Beltran MJ; Rodilla F; Gomez-Ruiz MD; Izquierdo R; Cabo J
    Cell Mol Biol; 1988; 34(6):649-54. PubMed ID: 3219699
    [No Abstract]   [Full Text] [Related]  

  • 8. [Uricosuric agents].
    Zöllner N; Gröbner W
    Arzneimittelforschung; 1971 Oct; 21(10):1500-3. PubMed ID: 5171869
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigation of low levels of plasma valproic acid concentration following simultaneous administration of sodium valproate and rizatriptan benzoate.
    Hokama N; Hobara N; Kameya H; Ohshiro S; Hobara N; Sakanashi M
    J Pharm Pharmacol; 2007 Mar; 59(3):383-6. PubMed ID: 17331341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of valproic acid in self-poisoned adults.
    Wilimowska J; Florek E; Piekoszewski W
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):22-6. PubMed ID: 16867166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of the effect of probenecid on pharmacokinetics of 99mTc-mercaptoacetyltriglycine in dogs.
    Kakizaki T; Yokoyama Y; Natsuhori M; Yamada N; Hashimoto M; Sato K; Ito N; Daniel GB
    J Vet Pharmacol Ther; 2005 Dec; 28(6):559-64. PubMed ID: 16343289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal effects of uricosuric agents in the chimpanzee.
    Fanelli GM; Bohn DL; Reilly SS
    J Pharmacol Exp Ther; 1971 Jun; 177(3):591-9. PubMed ID: 5568813
    [No Abstract]   [Full Text] [Related]  

  • 13. Population pharmacokinetics of valproate in Mexican children with epilepsy.
    Correa T; Rodríguez I; Romano S
    Biopharm Drug Dispos; 2008 Dec; 29(9):511-20. PubMed ID: 19067436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal physiopathology of uric acid. Pharmacologic study].
    Muñoz Sanz A; García Puig J; Mateos F; Barbado FJ
    Med Clin (Barc); 1982 Jan; 78(2):70-4. PubMed ID: 7070134
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-equivalence of bioavailability between generic and branded form of sodium valproate.
    Dhanaraj M; Jayavelu A
    Neurol India; 2004 Sep; 52(3):398. PubMed ID: 15472447
    [No Abstract]   [Full Text] [Related]  

  • 16. Possible multiple transporters were involved in hepatobiliary excretion of antofloxacin in rats.
    Hu J; Liu X; Xie L; Wang G; Liu H
    Xenobiotica; 2007 Jun; 37(6):579-91. PubMed ID: 17614005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics.
    Yasui-Furukori N; Uno T; Sugawara K; Tateishi T
    Clin Pharmacol Ther; 2005 Jan; 77(1):17-23. PubMed ID: 15637527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of valproic acid and carbapenem antibiotics with multidrug resistance-associated proteins in rat erythrocyte membranes.
    Ogawa K; Yumoto R; Hamada N; Nagai J; Takano M
    Epilepsy Res; 2006 Sep; 71(1):76-87. PubMed ID: 16806827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats.
    Nakajima Y; Mizobuchi M; Nakamura M; Takagi H; Inagaki H; Kominami G; Koike M; Yamaguchi T
    Drug Metab Dispos; 2004 Dec; 32(12):1383-91. PubMed ID: 15345660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic interaction between valproic acid and carbapenem-like antibiotics: a discussion of three cases].
    Llinares Tello F; Bosacoma Ros N; Hernández Prats C; Climent Grana E; Selva Otaolaurruchi J; Ordovás Baines JP
    Farm Hosp; 2003; 27(4):258-63. PubMed ID: 12966455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.